You are here:
Biotech & Pharma — Patented Technologies
Last Updated:February 26, 2026
About This Investor
JP-B-648
With roots in Japan, this investor is building pipeline coverage and invites relevant teasers. M&A rationale centers on Expand existing businesses overseas. They are specifically targeting: Manufacturing of eye care, skin care products, oral medications, and regenerative medicine – related products Only companies of a certain size and with patents or special technologies will be…
Biotech / Pharmaceuticals
Worldwide
Overseas Expansion
$130.8M - $654.2M
Majority/100% | Minority ok if step-up to majority feasible
Request Full Investor Profile
Similar Investors
JP-B-547
They are currently building a shortlist and welcome relevant introductions.
Facility Management
Malaysia, Singapore
Overseas Expansion
$3.27M - $9.81M
Majority / 100%
JP-B-590
Opportunity mandate: Their focus is: Priority is given to land
Logistics & Warehousing
ASEAN, Philippines, Thailand
Strategic Expansion
$65.4M - $196.3M
Majority / Minority
JP-B-657
They are currently building a shortlist and welcome relevant introductions.
Education Services
ASEAN, Vietnam
Overseas Expansion
$6.54M - $65.4M
100% (principle)